Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.
about
Proton therapy for pancreatic cancerRe-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreasA systematic review of the prognostic value of lymph node ratio, number of positive nodes and total nodes examined in pancreatic ductal adenocarcinoma.Adjuvant radiotherapy and lymph node status for pancreatic cancer: results of a study from the Surveillance, Epidemiology, and End Results (SEER) Registry Data.Prognostic value of the lymph node ratio after resection of periampullary carcinomas.Prognostic Implications of Lymph Node Status for Patients With Gallbladder Cancer: A Multi-Institutional Study.Neoadjuvant therapy prior to surgical resection for previously explored pancreatic cancer patients is associated with improved survivalAdjuvant chemoradiation for pancreatic cancer: what does the evidence tell us?The Association between Survival and the Pathologic Features of Periampullary Tumors Varies over Time.Bridging the gap between open and minimally invasive pancreaticoduodenectomy: the hybrid approachExpression of Gli1 and Wnt2B correlates with progression and clinical outcome of pancreatic cancer.Perineural Invasion and TAMs in Pancreatic Ductal Adenocarcinomas: Review of the Original Pathology Reports Using Immunohistochemical Enhancement and Relationships with Clinicopathological Features.The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704.The anatomic location of pancreatic cancer is a prognostic factor for survival.53BP1 expression is a modifier of the prognostic value of lymph node ratio and CA 19-9 in pancreatic adenocarcinoma.Pathology handling of pancreatoduodenectomy specimens: Approaches and controversies.Screening for pancreatic cancer: current evidence and future directions.Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma?Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratioThe number of lymph nodes identified in a simple pancreatoduodenectomy specimen: comparison of conventional vs orange-peeling approach in pathologic assessment.Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancerLymph node ratio is an independent prognostic factor for patients after resection of pancreatic cancer.Color-coded imaging of splenocyte-pancreatic cancer cell interactions in the tumor microenvironmentThe role and prognostic impact of lymph node ratio on stage III colorectal cancer.The role of lymph nodes in predicting the prognosis of ampullary carcinoma after curative resection.Impact of centralization of pancreatoduodenectomy on reported radical resections rates in a nationwide pathology databaseCharacterization of the role of the photosensitizer, deuteporfin, in the detection of lymphatic metastases in a pancreatic cancer xenograft model.Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resectionSurgery for gallbladder cancer in the US: a need for greater lymph node clearance.Ductal adenocarcinoma of the pancreatic head: a focus on current diagnostic and surgical conceptsObstructive Sleep Apnea and Pathological Characteristics of Resected Pancreatic Ductal Adenocarcinoma.Lymph-node ratio is an independent prognostic factor in patients with stage III colorectal cancer: a retrospective study from the Middle East.The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomyNodal sampling in pancreaticoduodenectomy: does it change our management?A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma.Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinomaConditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent.Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenocarcinoma.Preoperative Volume-Based PET Parameter, MTV2.5, as a Potential Surrogate Marker for Tumor Biology and Recurrence in Resected Pancreatic Cancer.Impact of lymph node ratio as a valuable prognostic factor in gallbladder carcinoma, focusing on stage IIIB gallbladder carcinoma.
P2860
Q26784227-7754E282-8480-4A1F-9049-F196A0DE81F0Q28075892-164653BE-8ACB-4219-B9BD-154BF428A536Q30240894-1BFED5CD-7F81-4B7E-A8A1-6D4585F74B66Q30580152-FE11AC9C-728D-4692-BDED-D09D4AFFF8DAQ33720957-1E5CDE14-191E-4AA7-BECA-F7F292EE3E16Q33742418-08099E4E-F341-40EA-87FB-C8EA862AAEC9Q33809495-A6E2900E-CFEC-4D9D-B8D4-8653751C4416Q33820788-7F2F9A17-A33B-4A78-98A4-D85CC7904AD7Q33914755-4287D5EA-9123-4591-877D-9C7EC6ADC298Q33990160-9E7037C5-31AD-4E66-95C2-06579BE664AAQ34029423-8CEB3BF6-6CB7-48FC-B3B7-4FA53B0C07C4Q34438719-3660AAA2-3D46-4394-9F5B-5F36AA0EC120Q34570963-E5212607-CFBF-42E4-9D28-5D24FAA48162Q34599751-0925702C-9BDE-4AD7-9627-C5FB523D8412Q34636501-6E1C90E2-F62C-49AC-B736-ADCCC124BDF2Q34664747-7AD748FC-883C-4443-8CC3-9EE2A6C16BCAQ35014007-C68A6C54-C770-49C6-B4E2-22CD8EC1BAEFQ35102202-89B0A469-FCCE-4389-A61A-B34D9B646A29Q35102376-71E232BE-A699-4CE0-AD32-9CB16F532B8CQ35186758-9EF701E0-EE6A-43E4-AA6C-F28EB2914F55Q35194671-2495F3CA-C689-480F-8C47-BF40B8D93F1DQ35234184-A2696199-2B1A-44A3-BC3F-E363D8B563CDQ35247738-04E22F6F-A295-4929-ADE0-8C1516BA3D61Q35714244-B34A14DF-23C6-4D50-85E3-C65E9C7778AEQ35885352-FEB8E2CD-8BB9-4D3D-830C-CDF21380F5B2Q35925005-F523F943-0CEA-4412-851E-F7795040678CQ35943244-C9089BE9-0BFD-4DFF-B8C6-3AD80B3EE03EQ36020137-8B32F8DE-4E03-4E61-9A2D-3176DCE50268Q36062633-E0611A08-1C42-41DD-A96D-87A62152E6EAQ36066808-EE2254CF-71A5-4086-B859-144CADF82536Q36161453-06717F46-7141-4BAC-BB33-BC64CD118FF0Q36168084-F45CB676-A4B3-4A0F-9F01-46BDF21F7198Q36258194-85D60C40-F916-41C5-9AF3-E79892FF3595Q36408353-121F748D-631E-4F61-B6E3-5798490E66CEQ36498482-75556C2F-AF3C-4CF3-AD0F-BAD23037525CQ36626534-917EB3BA-8B17-43A8-BC48-525353C60C08Q36626623-C82CD19D-A752-40CE-8283-57E75DC654A8Q36637079-DBB85E17-DC39-4EDA-ADE9-B5084D591359Q36663805-4490F324-C23D-4C1E-AA8B-51684285770EQ36675718-9C049EE3-6B09-4411-A634-2897A52A0B98
P2860
Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Prognostic relevance of lymph ...... nectomy for pancreatic cancer.
@en
type
label
Prognostic relevance of lymph ...... nectomy for pancreatic cancer.
@en
prefLabel
Prognostic relevance of lymph ...... nectomy for pancreatic cancer.
@en
P2093
P1433
P1476
Prognostic relevance of lymph ...... nectomy for pancreatic cancer.
@en
P2093
Ana L Gleisner
Charles J Yeo
Christopher Wolfgang
John L Cameron
Jordan M Winter
Keith D Lillemoe
Lia Assumpcao
Michael A Choti
Richard D Schulick
P304
P356
10.1016/J.SURG.2006.12.013
P407
P577
2007-03-23T00:00:00Z